Eastern Allergy Conference 2025
Thursday, May 29, 2025
3:30 – 4:00 Alpha-gal allergy update
Thomas Platts-Mills, MD
4:00 – 4:30 Update in stinging insect hypersensitivity
David Golden, MD
4:30 – 5:00 AIT update
David Bernstein, MD
5:00 – 5:15 Panel Discussion: Q & A
5:15 – 5:45 Vaccines and biologics
Nicole Chase, MD
5:45 – 6:15 Epinephrine: Alternative routes of administration
David Golden, MD
6:15 – 6:30 Panel Discussion: Q & A
Friday, May 30, 2025
7:45 – 8:15 Food allergy prevalence, severity, and disparities
Ruchi Gupta, MD
8:15 – 8:45 What you need to know about BTK inhibitors in the treatment of allergic
diseases
Melanie Dispenza, MD
8:45 – 8:55 Panel Discussion: Q & A
8:55 – 10:00 PBL: Chronic urticaria
Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD,
Nicole Chase, MD and Dana Wallace, MD
10:00 – 10:45 Coffee Break: Visits exhibits and posters
10:45 – 11:10 CSU treatment options when omalizumab fails
David Lang, MD
11:10 – 11:20 Panel Discussion: Q & A
11:20 – 11:45 Defining the role of the allergist in EOE management
Emily McGowan, MD
11:45 – 12:15 Role of IgG4 antibodies in allergic diseases
Thomas Platts-Mills, MD
12:15 – 12:25 Panel Discussion: Q & A
1:20 – 1:45 How to interpret genetic testing in IEI patients: When and what to order
Manish Butte, MD
1:45 – 2:15 Is it time for the allergist-immunologist to embrace AI in the diagnosis and treatment
of IEIs?
Joseph Bellanti, MD
2:15 – 2:25 Panel Discussion: Q & A
2:25 – 2:55 Music therapy in rare diseases
Raffi Tachdjian, MD
2:55 – 3:00 Panel Discussion: Q & A
Saturday, May 31, 2025
7:45 – 8:15 Clinical variability in primary immune regulatory disorders
Manish Butte, MD
8:15 – 8:45 What to do when your severe asthma patient does not respond to biologics
Dennis Ledford, MD
8:45 – 8:55 Panel Discussion: Q & A
8:55 – 10:00 PBL: Atopic dermatitis
Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD,
Ellen Sher, MD and Dana Wallace, MD
10:00 – 10:45 Coffee Break: Visit exhibits and posters
10:45 – 11:15 Treatment update for moderate/severe atopic dermatitis
Dana Wallace, MD
11:15 – 11:45 Adult atopic dermatitis: To patch or not to patch? This is the question
Jenny Murase, MD
11:45 – 11:55 Panel Discussion: Q & A
11:55 – 12:20 The medical management of CRS, NP & AERD in the biologic age
Kathleen Buchheit, MD
12:20 – 12:25 Panel Discussion: Q & A
1:20 – 2:20 Asthma phenotype debate
Asthma phenotyping should be done on all asthma patients
Juan Carlos Cardet, MD
Asthma phenotyping should be only done on severe asthma patients
Dennis Ledford, MD
2:20 – 2:30 Panel Discussion: Q & A
2:30 – 3:30 Patch test workshop
Jenny Murase, MD and Ellen Sher, MD
Sunday, June 1, 2025
8:15 – 8:45 Tales of the rash whisper: Untangling the mystery of adult recalcitrant
eczematous dermatitis
Jenny Murase, MD
8:45 – 9:15 HAE update
Raffi Tachdjian, MD
9:15 – 9:20 Panel Discussion: Q & A
10:15 – 10:45 Managing food allergies in each stage of life
Ruchi Gupta, MD
10:45 – 11:15 EGIDs update
Emily McGowan, MD
11:15 – 11:30 Panel Discussion: Q & A
Jointly Provided by the American College of Allergy, Asthma & Immunology (ACAAI)
and the Eastern Allergy Conference (EAC)
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and the Eastern Allergy Conference. The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of TBA AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for TBA contact hours.
This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity.
In compliance with the Americans with Disabilities Act, EAC requests that any participant in need of accommodations submit a written request to EAC well in advance.
Please contact Ginny Loiselle at 401-223-1309 or GinnyLoiselle@easternallergyconference.org.